They've pulled vaccines off the market before for having a 1 in 100,000 chance of causing Guillain-Barré syndrome.

Why are they still pushing a vaccine that is causing myocarditis at a rate of 1 in 1,000?

The answer, as always, is money. Look at how Pfizer doubled their revenue from 2020 to 2021.